NEW YORK — Scipio Bioscience said on Tuesday that it has raised €6.0 million ($6.5 million) in Series A financing.
The round was led by M Ventures, the venture capital arm of Merck KGaA. It also included existing investors Seventure Partners' Quadrivum I and High-Tech Gründerfonds, as well as new investors Financière Arbevel and Investiere.